Calcipotriol - Polichem

Drug Profile

Calcipotriol - Polichem

Alternative Names: P 3073

Latest Information Update: 12 Nov 2016

Price : $50

At a glance

  • Originator Polichem
  • Class Antipsoriatics; Cyclohexanes; Dihydroxycholecalciferols; Indenes; Vitamin D analogues
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase III Psoriasis

Most Recent Events

  • 29 Apr 2016 Biomarkers information updated
  • 04 Mar 2016 Efficacy data from a phase II trial in Psoriasis presented at the 74th Annual Meeting of the American Academy of Dermatology (AAD- 2016)
  • 18 Nov 2015 Polichem files an IND application with the US FDA in USA for Psoriasis (Nail psoriasis) (Polichem pipeline, November 2015)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top